Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021 2021-06-04 08:00
Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy 2021-06-04 08:00
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial 2021-06-04 02:00
RWDC Industries Appoints New Chief Financial Officer 2021-06-03 22:00
Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer 2021-06-03 17:09
Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited 2021-06-03 16:29
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood" 2021-06-03 08:00
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform 2021-06-03 06:00
First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma 2021-06-03 06:00
Nanoform raises its mid-term business targets for 2025 2021-06-02 21:42
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement 2021-06-02 21:00
Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs 2021-06-02 20:10
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
CPF launches plant-based "MEAT ZERO", eyeing to make it world's Top 3 alternative meat brand in 3-5 years 2021-06-02 17:40
ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021 2021-06-02 16:14
Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021 2021-06-02 08:00
Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody 2021-06-02 08:00
Antengene Announces Fifteen Clinical Studies and Results of Selinexor to be Presented at ASCO 2021 2021-06-02 08:00
Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site 2021-06-02 06:00
1 240 241 242 243 244 451